REGARD
Regard is a US healthcare AI company that sells an AI-powered clinical insights platform to hospitals, ingesting 100% of EHR data to recommend diagnoses and generate proactive clinical documentation across 150+ hospitals and 20+ states.
- Company typePrivate
- Founded2021
- HeadquartersMarina del Rey, CA, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What REGARD does
Regard is a private US healthcare AI company founded in 2021 that sells an AI-powered clinical insights platform to hospitals and health systems. The platform ingests and maps millions of EHR data points — analyzing approximately 50,000 data points per patient compared to the 3% physicians typically review — to recommend diagnoses with supporting clinical evidence and generate proactive clinical documentation at the point of care. The platform operates across four integrated modules: Clinical Notes (diagnostic support), Mid-Revenue Cycle (denial prevention), HCC Capture (risk adjustment), and Screening (care gap identification), with Max, an AI agent built on OpenAI's GPT-4, supporting real-time clinician workflows and an integrated ambient scribe capturing patient-physician conversations. The company has deployed across 150+ hospitals in 20+ US states, including enterprise-wide deployments at Banner Health (33 hospitals) and Cedars-Sinai.
The company generates revenue through enterprise SaaS subscriptions priced on a quote-based, annual billing cadence typical of health system SaaS deployments, distributed via direct enterprise sales, EHR marketplace integration (Epic App Orchard, Smart on FHIR), and a strategic partnership with Microsoft Dragon Copilot. The platform is ONC 2015 Cures Update certified and ISO 9001 compliant, meeting the procurement requirements of large US health systems. Customer outcomes include 17% increases in CC/MCC capture, $9.3M in denials prevented at WakeMed, $7M revenue increase at Penn Highlands, and reported 4x ROI per user at Sentara Health. The company has raised $61 million in Series B funding led by Oak HC/FT (July 2024) with participation from Cedars-Sinai Health Ventures and existing investors TenOneTen, Calibrate Ventures, and Techstars. Headcount is reported at 81 employees with headquarters in Marina del Rey/Los Angeles, CA and a New York office.
REGARD firmographics
Firmographics- Name
- REGARD
- Legal name
- Regard
- Website
- https://regard.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Regard is a US healthcare AI company that sells an AI-powered clinical insights platform to hospitals, ingesting 100% of EHR data to recommend diagnoses and generate proactive clinical documentation across 150+ hospitals and 20+ states.
- Ownership category
- akta.pro rank
REGARD industry classification
Industry- Product category
- Clinical Decision Support Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)
- akta.pro secondary industry
- Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)
Keywords
Where REGARD is headquartered
LocationHeadquarters
- HQ city
- Marina del Rey, CA
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
REGARD business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscription: Annual or multi-year subscription model for access to clinical insights platform, diagnostic recommendations, and documentation tools deployed within health system EHR environments
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS Platform |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
REGARD product offering
Product offeringCore offering
REGARD provides an AI-powered clinical insights platform that ingests and analyzes 100% of EHR chart data to recommend missed diagnoses and generate draft clinical documentation at the point of care. The platform is deployed inside Epic and other EHR systems via Smart on FHIR and is sold as an enterprise SaaS subscription to U.S. hospital and health-system customers, with workflow modules spanning clinical notes, mid-revenue cycle, HCC capture, and screening.
Product overview
Regard offers a unified AI-powered Proactive Documentation platform with four integrated clinical workflow solutions: Clinical Notes (AI-powered diagnostic support), Mid-Revenue Cycle (denial prevention and revenue capture), HCC Capture (risk adjustment), and Screening (care gap identification). The platform analyzes all EHR data to recommend diagnoses and generate draft clinical documentation at the point of care. Key capabilities include Max, an AI agent for real-time clinical support; integrated ambient scribe functionality; a no-code diagnostic builder for rapid specialty expansion; and impact analytics. The platform operates across more than 150 hospitals nationwide and supports single-patient and bulk EHI export via FHIR standards.
Differentiator
Problem solved
Functional benefit
Brands
- Max: AI agent that supports clinicians in real time, answering questions based on patient data, summarizing encounters, and supporting clinical workflows.
Products and services
- Clinical Notes
Quantifiable outcome
- 17% increase in CC/MCC capture; 4x ROI per user (Sentara Health)
- +5 more outcomes
Companies that use REGARD
Customer profileNamed customers17 records
Segments3 records
Ideal customer profiles1 record
REGARD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature10 records
REGARD partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and flagship.
- Microsoft Dragon CopilotcoreIntegration of Regard's Proactive Documentation platform with Microsoft Dragon Copilot enables health systems to access diagnostic insights and clinical context from EHR data combined with Dragon Copilot's natural language and ambient AI capabilities. The integration offers click-to-deploy simplicity for hospitals using Microsoft solutions.
- Cedars-SinaiflagshipCedars-Sinai partnered with Regard following success in the Cedars-Sinai Accelerator program. Cedars-Sinai Health Ventures also invested in Regard's Series B financing. Regard began its relationship with Cedars-Sinai in 2017 through the accelerator. The partnership aims to improve care quality by reducing documentation burdens and deploying AI-powered Proactive Documentation at Cedars-Sinai Medical Center and Cedars-Sinai Marina del Rey Hospital.
- WakeMed Health & HospitalscoreWakeMed Health partnered with Regard to implement AI documentation and clinical insights. Dr. David Kirk, former Chief Clinical Integration Officer at WakeMed, joined Regard as CMO in November 2025. WakeMed achieved $9.3M in denials prevented and expanded use of Regard across cardiology, surgery, pediatrics, and orthopedics.
- OpenAIcoreRegard expanded its relationship with OpenAI to release new core product functionalities and chatbot Max built on OpenAI's GPT-4 large language model. This partnership enables operationalizing LLMs in clinical workflows including automatic drafting of clinical notes, intelligent autocomplete, and documentation auditing against clinical guidelines.
- Banner HealthflagshipBanner Health partnered with Regard in June 2022 with a pilot at Banner Thunderbird Medical Center. Following successful adoption, Banner expanded to enterprise-wide deployment across all 33 acute-care hospitals in 2024. Banner is one of the largest nonprofit health systems in the US.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
REGARD competitors and assessment
Company assessmentBroad incumbents
- IKS Health: IKS Health is a broad incumbent providing technology-enabled clinical documentation, scribing, and revenue cycle services to health systems and hospitals. IKS competes with Regard across both ambient AI scribing and risk-adjustment/HCC capture workflows.
- Nuance DAX Copilot (Microsoft): Nuance DAX Copilot is Microsoft's ambient AI clinical documentation product, now directly integrated with Microsoft 365 and clinician workflows. It is both Regard's partner (via Dragon Copilot) and a broad incumbent competitive force in ambient clinical documentation for health systems.
- Epic Systems: Epic is the dominant EHR platform on which Regard is built and integrated; Epic is also building native AI ambient documentation and clinical decision support capabilities via Cosmos and its App Orchard. Epic is both Regard's core distribution substrate and a potential competing incumbent as it expands native AI.
Direct peers
- Nabla: Nabla is a direct competitor offering an ambient AI medical scribe that generates clinical notes from patient-physician conversations and integrates into EHR workflows. Both Nabla and Regard sell to hospitals and health systems looking to reduce clinician documentation burden.
- Suki AI: Suki is a direct competitor providing an AI clinical assistant and ambient scribe for physicians, generating documentation and clinical notes within EHRs. Both companies compete for the same enterprise health-system ambient documentation budgets.
- DeepScribe: DeepScribe is a direct competitor building ambient AI medical scribes for specialty practices and health systems, generating draft clinical notes from patient encounters. Both target documentation burden in the same buyer base.
- Augmedix (Commure): Augmedix (now part of Commure) is a direct competitor providing ambient medical documentation and AI-augmented scribing services to health systems; both compete for hospital documentation automation and ambient note generation.
- Abridge: Abridge is a direct competitor building AI-powered ambient clinical documentation and clinical conversation summarization for health systems, targeting the same physician burnout and EHR documentation problem Regard addresses. Both companies generate clinical notes from patient-physician encounters and integrate with major EHRs.
- Ambience Healthcare: Ambience is a direct competitor offering an AI medical scribe and CDI/coding platform for hospitals and health systems, generating clinical documentation from ambient conversation capture. Both compete for the same mid-revenue cycle, HCC capture, and ambient documentation wallet share.
Emerging players
- Commure (Athelas): Commure/Athelas is an emerging healthcare AI platform offering ambient documentation and revenue cycle solutions to hospitals and physician groups. They partially overlap with Regard in documentation automation and are scaling into enterprise health systems.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
REGARD social profiles
Digital presenceREGARD compliance and trust
Trust signalCompliance2 records
REGARD financial estimates
Financial estimateRevenue estimate
Valuation estimate
REGARD leadership team
Management profileNumber of profiles
Profiles15 records
REGARD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
REGARD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about REGARD
What does REGARD do?
REGARD provides an AI-powered clinical insights platform that ingests and analyzes 100% of EHR chart data to recommend missed diagnoses and generate draft clinical documentation at the point of care. The platform is deployed inside Epic and other EHR systems via Smart on FHIR and is sold as an enterprise SaaS subscription to U.S. hospital and health-system customers, with workflow modules spanning clinical notes, mid-revenue cycle, HCC capture, and screening.
Is REGARD a public or private company?
REGARD is a private company. It is classified as venture growth investor backed and is currently operating.
When was REGARD founded?
REGARD was founded in 2021. It employs 51 to 100 people.
Where is REGARD based?
REGARD is headquartered in Marina del Rey, CA, United States, in the North America region.
How does REGARD make money?
One revenue line is on record: saaS Platform Subscription.
Who are REGARD's main competitors?
Broad incumbents on record are IKS Health, Nuance DAX Copilot (Microsoft) and Epic Systems. Direct peers are Nabla, Suki AI, DeepScribe, Augmedix (Commure), Abridge and Ambience Healthcare. Commure (Athelas) is listed as an emerging player.
Does REGARD have an API?
No public API is recorded for REGARD.
What industry is REGARD in?
REGARD's product category is Clinical Decision Support Software. Its primary akta.pro industry code is HLACAHAD, Care Management & Coordination Platforms (case/disease management workflows), with a secondary code of HLACABAA, Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE). Its NAICS code is 518 and its SIC code is 8000.